US FDA's Office Of New Drugs Reorganization Approved, But Not Happening Overnight

 
• By Derrick Gingery

OND will grow to eight offices and 27 clinical divisions, which is slightly different than an early proposal.

FDAEntrance_1200x675
The reorganization of the FDA's Office of New Drugs is expected to take months to complete now that it has received congressional approval. • Source: File photo

More from Product Reviews

More from Pink Sheet